PHILADELPHIA – Researchers at the University of Pennsylvania School of Medicine have found that emotional well-being is not an independent factor affecting the prognosis of patients with head and neck cancers. This study appears in the December 1st issue of CANCER.
“The belief that a patient’s psychological state can impact the course and outcome of their cancer is one that has been prominent among patients and medical professionals, alike,” says James C. Coyne, PhD, Co-Leader, Cancer Control and Outcomes Program, Abramson Cancer Center; Professor of Psychology in Psychiatry at Penn; and lead author of the study. “This belief leads people to seek psychotherapy in the hopes of promoting survival. While there can be lots of emotional and social benefits of psychotherapy, patients should not seek such experiences solely on the expectation that they are extending their lives.”
Study participants were enrolled in two Radiation Oncology Group clinical trials and completed a baseline measure of quality of life questionnaire which included an Emotional Well-Being subscale. The outcome measure was overall survival. The study sample included 1,093 patients, and of this group, 646 died during the length of the study. With the coupling of this large sample and the uniformity of treatment and quality of care that is required in a clinical trial, this is one of the methodologically strongest studies in this area to-date.
The researchers found that emotional status was not a predictor of survival among this population. Additionally, no effects were observed when the researchers examined interactions between emotional well-being and study protocol, gender, primary cancer site, or stage of cancer. Therefore, the study reports that “this psychologic variable neither affected progression or death directly, nor functioned as a lurking variable.”
“While this study may not end the debate, it does provide the strongest evidence to-date that psychological factors are not independently prognostic in cancer management,” says Dr. Coyne.
Additional study authors are Thomas F. Pajak, PhD, American College of Radiology; Jonathan Harris, MS, American College of Radiology; Andre Konski, Fox Chase Cancer Center; Benjamin Movsas, Fox Chase Cancer Center; Kian Ang, MD, The University of Texas M.D. Anderson Cancer Center; and Deborah Watkins Bruner, PhD, School of Nursing, University of Pennsylvania.
PENN Medicine is
a $3.5 billion enterprise dedicated to the related missions
of medical education, biomedical research, and excellence in
patient care. PENN Medicine consists of the University of Pennsylvania
School of Medicine (founded in 1765 as the nation's first medical
school) and the University of Pennsylvania Health System.
Penn's School of Medicine is currently ranked #3 in the
nation in U.S.News & World Report's survey of top research-oriented
medical schools; and, according to most recent data from the
National Institutes of Health, received over $379 million in
NIH research funds in the 2006 fiscal year. Supporting 1,400
fulltime faculty and 700 students, the School of Medicine is
recognized worldwide for its superior education and training
of the next generation of physician-scientists and leaders
of academic medicine.
The University of Pennsylvania Health System includes
three hospitals — its flagship hospital,
the Hospital of the University of Pennsylvania, rated one of
the nation’s “Honor Roll” hospitals by U.S.News & World
Report; Pennsylvania Hospital, the nation's first hospital; and
Penn Presbyterian Medical Center — a
faculty practice plan; a primary-care provider network; two multispecialty
satellite facilities; and home care and hospice.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.